{"name":"ViroMissile, Inc.","slug":"viromissile-inc","ticker":"","exchange":"","domain":"viromissile.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOQXJGbzFpMjVXVm83ZzVQc2JkTDQxXzhFRk5fUXpCTTJvbUNDSWdDd0NLdmdxb2M5U2hoRnloY1Z1ZW5BY21IMDNTeU9rNEpVMk9Sc2o1c0Q0WXk0djlSNlFRTzFRdE1na0NMY2R2ZWJEeWhTNkV5aEd0QkhBZ1lyTHdtUlU4UkMzSDRJV05Wc0ZBVDBPdW8ybTV5ZHBqX1ViejFpcEVWSWxZWWZtZl9vc1ZqY0ZRb2pTQ2k0MkotcV9LNWRpSEJwY3poWEM5d2c1MlJycDUyUUtBbFYwNlJ4RlVPcERPeWtwbGlFUQ?oc=5","date":"2026-02-17","type":"trial","source":"GlobeNewswire","summary":"ViroMissile Expands Phase I IDOV-ImmuneTM Trial to U.S. Sites Following IND Clearance - GlobeNewswire","headline":"ViroMissile Expands Phase I IDOV-ImmuneTM Trial to U.S. Sites Following IND Clearance","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE8yUTlqSlBzVW16YnoxYmJZNS1VU2FGV1E5UldKMkxrODM4UVFGUGJNbnRMZnhNZGt4X2JKdXhXTW5RVllaSWY5V2lma1puWUxUZHd5eVlHNElGblNUUXJTZFdZUFlsbjdqM2lNQ0QtYk5VeTZkZVdSRzlfUXpaTW8?oc=5","date":"2026-02-09","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Pharma and biotech, January 2026 - pharmaphorum","headline":"Changing Faces: Pharma and biotech, January 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE55WTZpb1g3dVBodHlUMlRzVWlhZk42aDhYM2M2bm5QdGZrQ0Q5OEtwRzlJdDVrVVZ4VDExVHdTMEI1NVZmZENwR0VhcVEwOEpOX0N5SXU0N20ybDVqOFB4RUY2cWZlcDc4SjNaRUgxTURjXzM4ak5XcTljV25vUQ?oc=5","date":"2026-01-29","type":"pipeline","source":"PharmaLive","summary":"Pharma people on the move: Winter 2026 roundup - PharmaLive","headline":"Pharma people on the move: Winter 2026 roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQbWUyWnBBT2NvNFoxZ3NIbXFvempzM2d3bVRtX0loLW9QREMzVEFSeFQ4UEttNGItRHlrSGxEeS14bEdCOWdQdmhfZjh2ZThpcWlBLVM4ZFo0VG1vRTBjNzZ4WmpadEdEdktMaUNzSVZMSWViSEo0Zm9XWVl6TzNnbjVURmhjcjQySktzOTlrVm8xdWFPN1BMSXNFaDBsdU9iWG1OMmYxVzlqZmVhMnFtUEhSM0pJMnE0S0JGYWhYcmRHVlFv?oc=5","date":"2025-05-07","type":"pipeline","source":"PR Newswire","summary":"ViroMissile Unveils IDOV™ Platform: A Potential One-Shot Cure for Cancer - PR Newswire","headline":"ViroMissile Unveils IDOV™ Platform: A Potential One-Shot Cure for Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}